Chronic Myeloid Leukemia (CML) is a myeloproliferative neoplasm characterized by the presence of Philadelphia chromosome and BCR-ABL fusion oncogene. CML one illnesses that may be treated using Tyrosine Kinase Inhibitors (TKIs), type targeted therapy. Since TKIs are standard therapy, long-term survival has improved compared to chemotherapy interferon-alpha. For first-line treatment for CML, the...